|
2025-03-20 |
2025-03-19 |
VP
Vente planifiée
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
400
-0.2%
9,00
3 601 USD
|
400
-0.2%
|
9,00
|
3 601 USD
|
|
|
2025-03-20 |
2025-03-18 |
VP
Vente planifiée
|
Nichols William Garrett
Chief Medical Officer
Dirigeant
|
45 316
-46.3%
8,76
396 995 USD
|
45 316
-46.3%
|
8,76
|
396 995 USD
|
|
|
2025-03-20 |
2025-03-18 |
VP
Vente planifiée
|
Barone Francesca
Chief Scientific Officer
Dirigeant
|
32 146
-25.0%
8,76
281 673 USD
|
32 146
-25.0%
|
8,76
|
281 673 USD
|
|
|
2025-03-20 |
2025-03-18 |
VP
Vente planifiée
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
25 772
-10.2%
8,77
226 023 USD
|
25 772
-10.2%
|
8,77
|
226 023 USD
|
|
|
2025-03-19 |
2025-03-17 |
VP
Vente planifiée
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
31 278
-26.8%
8,82
275 947 USD
|
31 278
-26.8%
|
8,82
|
275 947 USD
|
|
|
2025-03-19 |
2025-03-17 |
VP
Vente planifiée
|
Schoch Charles
See Remarks
Dirigeant
|
5 000
-11.6%
8,83
44 169 USD
|
5 000
-11.6%
|
8,83
|
44 169 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
14 322
-12.9%
7,23
103 476 USD
|
14 322
-12.9%
|
7,23
|
103 476 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Schoch Charles
See Remarks
Dirigeant
|
9 511
-18.1%
7,23
68 717 USD
|
9 511
-18.1%
|
7,23
|
68 717 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
21 704
-7.9%
7,23
156 811 USD
|
21 704
-7.9%
|
7,23
|
156 811 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Barone Francesca
Chief Scientific Officer
Dirigeant
|
13 534
-10.9%
7,23
97 783 USD
|
13 534
-10.9%
|
7,23
|
97 783 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Nichols William Garrett
Chief Medical Officer
Dirigeant
|
10 428
-11.6%
7,23
75 342 USD
|
10 428
-11.6%
|
7,23
|
75 342 USD
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
21 172
-7.2%
8,22
173 996 USD
|
21 172
-7.2%
|
8,22
|
173 996 USD
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
Schoch Charles
See Remarks
Dirigeant
|
9 971
-15.9%
8,22
81 944 USD
|
9 971
-15.9%
|
8,22
|
81 944 USD
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
Barone Francesca
Chief Scientific Officer
Dirigeant
|
13 673
-9.9%
8,22
112 367 USD
|
13 673
-9.9%
|
8,22
|
112 367 USD
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
14 545
-11.6%
8,22
119 534 USD
|
14 545
-11.6%
|
8,22
|
119 534 USD
|
|
|
2025-01-10 |
2025-01-08 |
V
Vente
|
Nichols William Garrett
Chief Medical Officer
Dirigeant
|
10 799
-10.7%
8,22
88 749 USD
|
10 799
-10.7%
|
8,22
|
88 749 USD
|
|
|
2024-12-18 |
2024-12-16 |
A
Achat
|
Manning Paul B
Administrateur non-exécutif
|
750 000
+135.4%
6,00
4 500 000 USD
|
750 000
+135.4%
|
6,00
|
4 500 000 USD
|
|
|
2024-12-18 |
2024-12-16 |
A
Achat
|
Manning Paul B
Administrateur non-exécutif
|
500 000
+77.8%
6,00
3 000 000 USD
|
500 000
+77.8%
|
6,00
|
3 000 000 USD
|
|
|
2024-12-03 |
2024-11-29 |
V
Vente
|
Barone Francesca
Chief Scientific Officer
Dirigeant
|
22 081
-13.8%
4,56
100 592 USD
|
22 081
-13.8%
|
4,56
|
100 592 USD
|
|
|
2024-12-03 |
2024-11-29 |
V
Vente
|
Nichols William Garrett
Chief Medical Officer
Dirigeant
|
13 935
-12.2%
4,56
63 482 USD
|
13 935
-12.2%
|
4,56
|
63 482 USD
|
|
|
2024-12-03 |
2024-11-29 |
V
Vente
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
48 847
-14.2%
4,56
222 527 USD
|
48 847
-14.2%
|
4,56
|
222 527 USD
|
|
|
2024-12-03 |
2024-11-29 |
V
Vente
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
20 392
-14.0%
4,56
92 898 USD
|
20 392
-14.0%
|
4,56
|
92 898 USD
|
|
|
2024-10-15 |
2024-10-15 |
V
Vente
|
Aguilar-Cordova Estuardo
Actionnaire important
|
10 412
-1.1%
6,03
62 784 USD
|
10 412
-1.1%
|
6,03
|
62 784 USD
|
|
|
2024-10-15 |
2024-10-14 |
V
Vente
|
Aguilar-Cordova Estuardo
Actionnaire important
|
15 000
-1.6%
6,02
90 300 USD
|
15 000
-1.6%
|
6,02
|
90 300 USD
|
|
|
2024-10-15 |
2024-10-11 |
V
Vente
|
Aguilar-Cordova Estuardo
Actionnaire important
|
15 000
-1.6%
6,05
90 750 USD
|
15 000
-1.6%
|
6,05
|
90 750 USD
|
|
|
2024-10-03 |
2024-10-03 |
V
Vente
|
Aguilar-Cordova Estuardo
Actionnaire important
|
1 800
-0.2%
6,85
12 330 USD
|
1 800
-0.2%
|
6,85
|
12 330 USD
|
|
|
2024-10-03 |
2024-10-02 |
V
Vente
|
Aguilar-Cordova Estuardo
Actionnaire important
|
26 988
-2.7%
6,92
186 757 USD
|
26 988
-2.7%
|
6,92
|
186 757 USD
|
|
|
2024-07-19 |
2024-07-17 |
V
Vente
|
Barone Francesca
Chief Scientific Officer
Dirigeant
|
14 051
-8.1%
6,47
90 947 USD
|
14 051
-8.1%
|
6,47
|
90 947 USD
|
|
|
2024-07-19 |
2024-07-17 |
V
Vente
|
Schoch Charles
See Remarks
Dirigeant
|
9 884
-13.7%
6,47
63 975 USD
|
9 884
-13.7%
|
6,47
|
63 975 USD
|
|
|
2024-07-19 |
2024-07-17 |
V
Vente
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
22 528
-6.4%
6,47
145 815 USD
|
22 528
-6.4%
|
6,47
|
145 815 USD
|
|
|
2024-07-19 |
2024-07-17 |
V
Vente
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
14 851
-9.2%
6,47
96 125 USD
|
14 851
-9.2%
|
6,47
|
96 125 USD
|
|
|
2024-07-19 |
2024-07-17 |
V
Vente
|
Nichols William Garrett
Chief Medical Officer
Dirigeant
|
10 875
-8.7%
6,47
70 390 USD
|
10 875
-8.7%
|
6,47
|
70 390 USD
|
|
|
2024-07-15 |
2024-07-11 |
V
Vente
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
13 330
-7.7%
5,97
79 625 USD
|
13 330
-7.7%
|
5,97
|
79 625 USD
|
|
|
2024-07-15 |
2024-07-11 |
V
Vente
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
20 293
-5.4%
5,97
121 218 USD
|
20 293
-5.4%
|
5,97
|
121 218 USD
|
|
|
2024-07-15 |
2024-07-11 |
V
Vente
|
Nichols William Garrett
Chief Medical Officer
Dirigeant
|
9 769
-7.2%
5,97
58 354 USD
|
9 769
-7.2%
|
5,97
|
58 354 USD
|
|
|
2024-07-15 |
2024-07-11 |
V
Vente
|
Schoch Charles
See Remarks
Dirigeant
|
8 897
-10.9%
5,97
53 145 USD
|
8 897
-10.9%
|
5,97
|
53 145 USD
|
|
|
2024-07-15 |
2024-07-11 |
V
Vente
|
Barone Francesca
Chief Scientific Officer
Dirigeant
|
12 645
-6.8%
5,97
75 534 USD
|
12 645
-6.8%
|
5,97
|
75 534 USD
|
|
|
2022-12-12 |
2022-12-09 |
A
Achat
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
12 935
+46.1%
1,92
24 835 USD
|
12 935
+46.1%
|
1,92
|
24 835 USD
|
|
|
2022-12-12 |
2022-12-09 |
A
Achat
|
Amello Jason
Chief Financial Officer
Dirigeant
|
2 468
+79.6%
1,93
4 763 USD
|
2 468
+79.6%
|
1,93
|
4 763 USD
|
|
|
2022-12-12 |
2022-12-09 |
A
Achat
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
10 358
+345.3%
1,93
19 991 USD
|
10 358
+345.3%
|
1,93
|
19 991 USD
|
|
|
2022-12-12 |
2022-12-09 |
A
Achat
|
Martell Christopher
Administrateur non-exécutif
|
23 950
+18.7%
1,92
45 984 USD
|
23 950
+18.7%
|
1,92
|
45 984 USD
|
|
|
2022-12-12 |
2022-12-09 |
A
Achat
|
PAPA JOSEPH C
Administrateur non-exécutif
|
35 018
+1161.8%
1,94
67 935 USD
|
35 018
+1161.8%
|
1,94
|
67 935 USD
|
|
|
2022-12-12 |
2022-12-08 |
A
Achat
|
Tak Paul Peter
Chief Executive Officer
Administrateur exécutif
|
3 050
+12.2%
1,70
5 185 USD
|
3 050
+12.2%
|
1,70
|
5 185 USD
|
|
|
2022-12-12 |
2022-12-08 |
A
Achat
|
Amello Jason
Chief Financial Officer
Dirigeant
|
3 100
+inf%
1,69
5 239 USD
|
3 100
+inf%
|
1,69
|
5 239 USD
|
|
|
2022-12-12 |
2022-12-08 |
A
Achat
|
Barone Francesca
Chief Scientific Officer
Dirigeant
|
1 238
+82.5%
1,61
1 993 USD
|
1 238
+82.5%
|
1,61
|
1 993 USD
|
|
|
2022-12-12 |
2022-12-08 |
A
Achat
|
Tyagarajan Seshu
Chief Technology Officer
Dirigeant
|
3 000
+inf%
1,69
5 070 USD
|
3 000
+inf%
|
1,69
|
5 070 USD
|
|
|
2022-12-12 |
2022-12-08 |
A
Achat
|
Martell Christopher
Administrateur non-exécutif
|
3 050
+2.4%
1,68
5 124 USD
|
3 050
+2.4%
|
1,68
|
5 124 USD
|
|
|
2022-12-12 |
2022-12-08 |
A
Achat
|
PAPA JOSEPH C
Administrateur non-exécutif
|
3 014
+inf%
1,70
5 124 USD
|
3 014
+inf%
|
1,70
|
5 124 USD
|
|
|
2021-08-02 |
2021-07-29 |
A
Achat
|
Martell Christopher
Administrateur non-exécutif
|
125 000
+inf%
8,00
1 000 000 USD
|
125 000
+inf%
|
8,00
|
1 000 000 USD
|
|
